| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a569b1f7828cb235d1ee2af578b7bf7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa483f86cc4003166ba4a17f7117bc12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d85899b09a301b541d4b49d4809d3162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d3911a97372cb96f24081487cf4eb5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a70b05f3bdf7f6e9aaf7a41ac3aacdc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2005-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f39a26844a424b81cc53c276b03fd60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3592d9210058b25f2f06bf625f0f3ba6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21c5b40e36bd3d0e0d7a43fdba64b936
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3847dc69d3eb24c77122f3a1e006a656 |
| publicationDate |
2006-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006021455-A1 |
| titleOfInvention |
Fast release composition including melt granules of a moisture sensitive drug and process for manufacturing thereof |
| abstract |
Solid oral dosage forms that include melt granules of a moisture-sensitive therapeutic compound and a hydrophobic melt component. The melt granules better protect the therapeutic compound from hydrolytic degradation. Such solid oral dosage forms also possess immediate-release characteristics rather than that associated with extended-release or controlled-release drug products. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-201002256-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7915427-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007128801-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018050892-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2377518-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7754757-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8053465-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10369108-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009129943-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3087975-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8143427-B2 |
| priorityDate |
2004-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |